三聚类CDDO和CDDO-EA通过调节核体组合来抑制乙型肝炎病毒的复制
Qiang Gao1, Ge Yang1, Ya Wang1
1CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, NHC Key Laboratory of Biotechnology for Microbial Drugs, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
International journal of molecular sciences
|January 10, 2026
概括
两个合成的三类化合物CDDO和CDDO-EA通过破坏HBV囊组合来抑制乙型肝炎病毒 (HBV) DNA复制. 这些化合物显示出作为慢性HBV感染的新型抗病毒药物的潜力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药用化学 医学化学
背景情况:
- 慢性乙型肝炎病毒 (HBV) 感染是一个重要的全球健康问题,治疗治疗方法有限.
- 合成的三聚胺在肝脏疾病中具有潜在的治疗益处.
研究的目的:
- 识别针对HBV的新型抗病毒药物.
- 为了研究合成三类药物CDDO和CDDO-EA对HBV的作用机制.
主要方法:
- 合成三基查HBV抑制.
- 对HBVDNA复制,pgRNA水平和核心蛋白质表达的分析.
- 粒子凝测定,西部斑点,CETSA,SPR,以及分子对接.
- 评估与拉米丁的协同效应.
主要成果:
- CDDO和CDDO-EA显著抑制了HBV DNA复制.
- 这些化合物降低了细胞外和细胞内的pgRNA,而不影响总的pgRNA或核心蛋白质水平.
- CDDO和CDDO-EA促进了空白HBV囊体的形成和调节的核心蛋白酸化.
- 已经证明了CDDO和CDDO-EA与HBV核心蛋白质二次二次接口的直接结合.
- 在减少HBVDNA方面,CDDO-EA与拉米武丁具有协同作用.
结论:
- CDDO和CDDO-EA作为新型HBV囊组装调节器.
- 这些三类化合物代表了开发新抗HBV疗法的有希望的化合物.
相关概念视频
Viruses with RNA Genomes
793
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
793
Eukaryotic Transcription Inhibitors
10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
S-Cdk Initiates DNA Replication
5.3K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
5.3K
Subviral Agents
502
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
502


